血清の尿酸と血清のクレアチニンの比率の予後的な役割は,st上昇性心筋梗塞と多血管性冠動脈疾患の患者で
Ayca Gumusdag1, Muhsin Kalyoncuoglu2, Huseyin Oguz3
1Department Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Education Research Hospital, University of Health Sciences, Istanbul, Türkiye.
Cardiology journal
|September 5, 2025
まとめ
血清尿酸と血清クレアチニン比 (SUA/ SCr) は,ST上昇性心筋梗塞 (STEMI) と多血管性冠動脈疾患 (MVCAD) の患者における早期の主要な心血管および脳血管疾患 (MACCE) を予測することができる. 30日以内にこれらの有害事象のリスクが増加することを示しています.
科学分野:
- 心臓病科
- バイオマーカー
- 臨床的予測
背景:
- ST上昇性心筋梗塞 (STEMI) と多血管性冠動脈疾患 (MVCAD) は,重要な早期心血管および脳血管疾患 (MACCE) と関連しています.
- これらのMACCEの信頼性の高い予測要因を特定することは,適切な介入と患者の成果の改善に不可欠です.
研究 の 目的:
- STEMIとMVCADの患者における早期MACCEに対する血清尿酸と血清クレアチニン比率 (SUA/ SCr) の予測値を調べる.
- この患者集団におけるリスク分層の潜在的なバイオマーカーとしてSUA/SCrを評価する.
主な方法:
- STEMI と MVCAD の患者572人を対象とした遡及研究が実施されました.
- 血清尿酸と血清クレアチニンは,入院時に測定され,SUA/ SCrを計算した.
- 多変量コックス回帰とカプラン- メイヤー分析により,MACCEを特定するために患者さんを30日間追跡した.
主要な成果:
- STEMIとMVCAD患者の30日間のMACCEを独立して予測したより高いSUA/ SCrレベル (HR: 1. 1029, p = 0. 011).
- SUA/SCrの曲線下の面積は0.606 (p = 0.002) であり,その予測能力を示している.
- カプラン- メイヤー曲線は,SUA/ SCr > 4. 58 (p = 0. 001) の患者に著しく高いMACCEを示した.
結論:
- SUA/SCr比は新しい,有望な酸化および炎症バイオマーカーです.
- SUA/SCrは,STEMIとMVCADの患者における30日間のMACCEの潜在的予測因子として機能する.
- この比率は,これらの高リスク患者の治療決定に役立ちます.
関連する概念動画
01:24Serum Studies: Renal Function Tests
42
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
42
01:30Acute Coronary Syndrome III: Diagnostic Studies
23
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
01:17Factors Affecting Renal Clearance: Renal Impairment
154
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
154
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
331
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
331
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
54
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
54
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
213
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
213